why choose us

First received: March 31, 2023

Clinical Trial: Clinical Utility of MyProstateScore 2.0 P2

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: An Extension Study of LynxDx's Ongoing Determination of Clinical Utility of MyProstateScore 2.0 Test: A Combined CPV-Based, Patient-Level Assessment

Brief Summary: This is an extension of an ongoing study.Preliminary results from the ongoing study indicate that the MyProstateScore 2.0 (MPS 2.0) Test is significantly improving early diagnosis of prostate cancer.This extension will allow us to ask the study participants in the ongoing study to share patient-level data for chart abstraction.The specific purpose of this study is to generate high-quality real-world data on the clinical utility of LynxDx's new MPS 2.0 test.

Read more